UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 515

Sortiert nach

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

Cell reports (Cambridge), 2016-08, Vol.16 (5), p.1259-1272

2016

Link zum Volltext

Verfügbarkeit prüfen

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

The Journal of clinical investigation, 2016-09, Vol.126 (9), p.3219-3235

2016

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

Cancer and metastasis reviews, 2010-03, Vol.29 (1), p.37-48

Gazdar, Adi F.

2010

Link zum Volltext

Verfügbarkeit prüfen

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

Human mutation, 2014-06, Vol.35 (6), p.756-765

2014

Link zum Volltext

Verfügbarkeit prüfen

Malignant mesothelioma: Facts, Myths, and Hypotheses

Journal of cellular physiology, 2012-01, Vol.227 (1), p.44-58

2012

Link zum Volltext

Verfügbarkeit prüfen

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers

PloS one, 2012-06, Vol.7 (6), p.e39167-e39167

2012

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models

Cancer cell, 2011-09, Vol.20 (3), p.289-299

2011

Link zum Volltext

Verfügbarkeit prüfen

Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations

Molecular cancer research, 2013-06, Vol.11 (6), p.638-650

2013

Link zum Volltext

Verfügbarkeit prüfen

Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma

JNCI : Journal of the National Cancer Institute, 2017-03, Vol.109 (3), p.1

2017

Link zum Volltext

Verfügbarkeit prüfen

Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer

Genes & development, 2016-06, Vol.30 (11), p.1289-1299

2016

Link zum Volltext

Verfügbarkeit prüfen

The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung

Journal of thoracic oncology, 2015-04, Vol.10 (4), p.553-564

2015

Link zum Volltext

Verfügbarkeit prüfen

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

Cancer cell, 2006-07, Vol.10 (1), p.25-38

2006

Link zum Volltext

Verfügbarkeit prüfen

DNA Repair and Survival in Lung Cancer — The Two Faces of Janus

The New England journal of medicine, 2007-02, Vol.356 (8), p.771-773

Gazdar, Adi F

2007

Link zum Volltext

Verfügbarkeit prüfen

A Translational View of the Molecular Pathogenesis of Lung Cancer

Journal of thoracic oncology, 2007-04, Vol.2 (4), p.327-343

2007

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer preneoplasia

Annual review of pathology, 2006-01, Vol.1 (1), p.331-348

2006

Link zum Volltext

Verfügbarkeit prüfen

Personalized Medicine and Inhibition of EGFR Signaling in Lung Cancer

The New England journal of medicine, 2009-09, Vol.361 (10), p.1018-1020

Gazdar, Adi F

2009

Link zum Volltext

Verfügbarkeit prüfen

Knockdown of ZEB1 , a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells

Cancer letters, 2010-10, Vol.296 (2), p.216-224

2010

Link zum Volltext

Verfügbarkeit prüfen

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (5), p.1642-1646

2005

Link zum Volltext

Verfügbarkeit prüfen

Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy

Molecular cancer therapeutics, 2011-02, Vol.10 (2), p.336-346

2011

Link zum Volltext

Verfügbarkeit prüfen

Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors

Cell reports (Cambridge), 2017-05, Vol.19 (8), p.1669-1684

2017

Link zum Volltext

Verfügbarkeit prüfen

The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers

Clinical cancer research, 2005-02, Vol.11 (3), p.1167-1173

2005

Link zum Volltext

Verfügbarkeit prüfen

Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling

Cancer research (Chicago, Ill.), 2015-02, Vol.75 (4), p.666-675

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 515

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(478)
Mit Volltextzugriff
(488)

Publikationsform

Sprache

Englisch
(511)
Japanisch
(102)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(321)
Science & Technology
(313)
Life Sciences & Biomedicine
(304)
Oncology
(216)
Biological And Medical Sciences
(146)
Lung Neoplasms - Genetics
(135)
Medical Sciences
(131)
Female
(108)
Lung Neoplasms - Pathology
(103)
Male
(93)
Pneumology
(87)
Tumors Of The Respiratory System And Mediastinum
(85)
Lung Cancer
(75)
Tumor Cells, Cultured
(73)
Animals
(72)
Carcinoma, Non-Small-Cell Lung - Genetics
(71)
Middle Aged
(69)
Aged
(64)
Cell Line
(56)
Mutation
(52)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer

Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

Malignant mesothelioma: Facts, Myths, and Hypotheses

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers

Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models

Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations

Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma

Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer

The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung

Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

DNA Repair and Survival in Lung Cancer — The Two Faces of Janus

A Translational View of the Molecular Pathogenesis of Lung Cancer

Lung cancer preneoplasia

Personalized Medicine and Inhibition of EGFR Signaling in Lung Cancer

Knockdown of ZEB1 , a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells

A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas

Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy

Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors

The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers

Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling

Aktive Filter

Suchergebnisse filtern